Patents by Inventor Maureen Barnes

Maureen Barnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DOSAGE FORMS FOR THE TREATMENT OF LIVER DISORDERS AND METHODS OF PREPARING THE SAME
    Publication number: 20260248825
    Abstract: The present disclosure is directed to oral forms of TR? agonists and methods of preparing the same. The disclosure provides oral dosage forms of TR? agonists with improved stability properties that allow for storage under normal conditions.
    Type: Application
    Filed: November 15, 2023
    Publication date: August 27, 2026
    Inventors: Geoffrey E. Barker, Maureen Barnes, William Hoye
  • Compositions and methods for the treatment of liver disorders
    Patent number: 12678430
    Abstract: The present disclosure is directed to FXR agonists, pharmaceutical compositions thereof, and methods of using the same for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis, either alone or in combination with thyroid receptor agonists.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: July 14, 2026
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Kader Yagiz, Maureen Barnes, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20260124271
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: December 19, 2025
    Publication date: May 7, 2026
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20260097126
    Abstract: Disclosed herein are formulations of small molecule GIP/GLP-1 dual receptor agonists and uses thereof.
    Type: Application
    Filed: July 18, 2023
    Publication date: April 9, 2026
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Brahmachary Enugurthi, Jake Gonzalez
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20260078149
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: September 17, 2025
    Publication date: March 19, 2026
    Inventors: Brian LIAN, Geoffrey E. BARKER, Kader YAGIZ, Maureen BARNES, Erland STEVENS
  • Compositions and methods for the treatment of metabolic and liver disorders
    Patent number: 12533391
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Grant
    Filed: August 10, 2023
    Date of Patent: January 27, 2026
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • Compositions and methods for the treatment of metabolic and liver disorders
    Patent number: 12421282
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: September 23, 2025
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Kader Yagiz, Maureen Barnes, Erland Stevens
  • Compositions and methods for the treatment of metabolic and liver disorders
    Patent number: 12318426
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Grant
    Filed: July 16, 2024
    Date of Patent: June 3, 2025
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20250171499
    Abstract: Disclosed herein are formulations of small molecule GIP/GLP-1 dual receptor agonists and uses thereof.
    Type: Application
    Filed: January 11, 2023
    Publication date: May 29, 2025
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz
  • ORAL DOSAGE FORMS OF TR? AGONIST VK2809 FOR THE TREATMENT OF LIVER DISORDERS AND METHODS OF PREPARING THE SAME
    Publication number: 20250134913
    Abstract: The present disclosure is directed to oral dosage forms of TR? agonist VK2809 and methods of preparing the same. The disclosure provides oral dosage forms of VK2809 with improved stability and solubility properties that allow for storage under normal conditions through the use of spray-drying with one or more polymers selected from the group consisting of: polyvinyl pyrrolidone (PVP), polyvinyl pyrrolidinone-vinyl acetate copolymer (PVP-VA), polyvinyl alcohol (PVA), polyacrylic acid (PAA), polyethylene oxide) (PEO), hydroxypropyl cellulose (HPC), hydroxypropyl methyl cellulose (HPMC), copovidone, poloxamer 407, hypromellose acetate succinate (HPMCAS), polyacrylates and combinations thereof.
    Type: Application
    Filed: February 13, 2023
    Publication date: May 1, 2025
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, William Hoye
  • POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A COMPOUND
    Publication number: 20250034183
    Abstract: Disclosed herein are thyroid receptor agonist compounds, polymorphic forms, pharmaceutical compositions, the method of use, and preparation thereof. Some embodiments relate to crystalline forms of Compound 1 and salts thereof.
    Type: Application
    Filed: February 13, 2023
    Publication date: January 30, 2025
    Inventors: Geoffrey E. Barker, Maureen Barnes
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20240366714
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: July 16, 2024
    Publication date: November 7, 2024
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20240239843
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions. pharmaceutical compositions. the use and preparation thereof.
    Type: Application
    Filed: September 12, 2022
    Publication date: July 18, 2024
    Inventors: Brian Lian, Geoffrey E. Barker, Kader Yagiz, Maureen Barnes, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20240058415
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: August 10, 2023
    Publication date: February 22, 2024
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • Compositions and methods for the treatment of metabolic and liver disorders
    Patent number: 11744873
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: September 5, 2023
    Assignee: Viking Therapeutics, Inc.
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISORDERS
    Publication number: 20230226038
    Abstract: The present disclosure is directed to FXR agonists, pharmaceutical compositions thereof, and methods of using the same for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis, either alone or in combination with thyroid receptor agonists.
    Type: Application
    Filed: June 7, 2021
    Publication date: July 20, 2023
    Inventors: Brian Lian, Geoffrey E. Barker, Kader Yagiz, Maureen Barnes, Erland Stevens
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS
    Publication number: 20230105647
    Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
    Type: Application
    Filed: November 18, 2022
    Publication date: April 6, 2023
    Inventors: Brian Lian, Geoffrey E. Barker, Maureen Barnes, Kader Yagiz, Erland Stevens